Paris - Monaco
+06 48 48 87 40
Follow us on



Forum Centre Scientifique de Monaco - Monaco 25 November 2021

Dr Graziana Scigliuolo presented “Advances in the treatment of sickle cell disease ”. 

The third Forum of CSM was organized at « Lycee Albert 1er » in Monaco.
This event allowed to share the most relevant discoveries of CSM research teams. An updates of the ongoing studies and achievements from different CSM groups were presented.
Dr Scigliuolo presented the results of the latest studies of Monacord group on Sickle Cell Disease and made a brief overview of the innovative treatments currently available for this genetic disease.

Stem cell transplantation in childhood. Biotechnological advances, ethical issues and worldwide equal access - Rome, Italy, September 26-28, 2019

In order to seal the scientific collaboration agreement between the Scientific center of Monaco (CSM) and the  “Bambino Gesù” Hospital (Rome, Italy) an international congress was held in the Vatican from September 26-28, 2019 under the Scientific Presidency of Prof. Locatelli and Prof. Gluckman. The congress brought together high-level international scientific speakers, which attracted a significant number of participants.
Prof Gluckman and her team, represented by Drs Barbara Cappelli Lauro and Graziana Scigliuolo, shared the results of studies on sickle cell disease, including the latest advances in hematopoietic stem cell transplantation.


Pre EBMT meeting - Paris (France), March 23, 2019

Prof. Eliane Gluckman organized an international  congress to review the use of umbilical cord blood for the treatment of malignant and non-malignant hematological diseases with renowned scientists in this field.
The topics covered during the congress were:
1. Main current studies on umbilical cord blood worldwide
2. Relevant clinical issues and future studies on cord blood stem cells
3. New cell therapies using cord blood stem cells

Forum Centre Scientifique de Monaco - Monaco, 18 Avril 2018

Dr Barbara Cappelli presented “Innovative therapies for genetic and immunological diseases”. 

The second Forum of CSM was organized at Auditorium Ranieri III in Monaco. This event included the most relevant discoveries of CSM research teams. An updates of the ongoing studies and achievements from different CSM groups were presented. Dr Cappelli has presented the latest studies of Monacord group on Sickle cell disease.


Workshop Cordons de Vie - Monaco, October 2016

Since 2012, the “Cordons de Vie” Association aims to  financially support scientific researchers working on Umbilical Cord Stem Cell Transplantation.
On October 14 2016, the results of the projects financed by the association have been presented.
An update on the latest discoveries on stem cell transplantation, umbilical cord stem cells, genetic hematological diseases such as Sickle Cell Disease and the use of new innovative treatments have been addressed. 

57th ASH Annual Meeting and Exposition, Orlando, FL, USA, 5-8 December 2015

Hematopoietic Stem Cell Transplantation from HLA Identical Sibling for Sickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Pediatric Disease Working Party and CIBMTR The final analysis was presented by Dr. Cappelli Lauro at the American Society of Hematology (ASH) that was held in Orlando on December 5-8 2015. ASH Annual Meeting is the world’s premier event in malignant and non-malignant hematology. The meeting provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field, as well as a global community of more than 25,000 hematology professionals from every subspecialty. The results of the international study on hematopoietic stem cell transplantation from an HLA identical sibling in patients with sickle cell disease were presented. This is the first international study on the use of HSCT for SCD. Data from 1000 children and adults who received an HLA identical sibling as first transplant in Europe, USA and Brazil. The excellent results obtained in terms of overall survival and event free survival demonstrate that transplantation in SCD is feasible with acceptable risk of early and late complications if compared to the expected quality of life of severe SCD patients. This study has therefore been distributed worldwide since it was selected for oral presentation and for a press conference, a publication for Highlights of ASH and best of ASH. Invited for: Press conference on sickle cell disease, Invited by Dr. David Williams (ASH President) Oral Presentation Session  Hemoglobinopathies, Excluding Thalassemia – Clinical: Promising Therapies in Sickle Cell Disease time 10.30-12.00 Moderators: Jane A little, MD, Case Western Best of ASH session 2016 Highlights of ASH® in North America

World cord blood congresses

Under the high patronage of His Serene Highness Prince Albert II of Monaco, two International Congresses on « Innovative Therapies in the Field of Cell Therapy and the Use of Umbilical Cord Blood Cells » were held in the Principality of Monaco, in 2013 and in 2015. Organized by the Monacord group, the Monaco Scientific Center, the European School of Haematology, Eurocord and Netcord, in partnership with the World Bone Marrow Transplant Organization, World Marrow Donor Association and the European Blood and Marrow Transplant Group, the best specialists in the world were brought together and had fruitful multidisciplinary exchanges on the recent researches in the field of stem cells and their possible therapeutic applications.